Accel Research Site - Birmingham Clinical Research Unit is a clinical research site located in Birmingham, Alabama, United States 35216.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Accel Research Site - Birmingham Clinical Research Unit has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Type 2 Diabetes Mellitus (T2DM), Meningococcal Immunisation, Healthy Volunteers.
Sponsors: Amgen, Sanofi Pasteur, a Sanofi Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Alabama · View every site in Birmingham
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Accel Research Site - Birmingham Clinical Research Unit has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Accel Research Site - Birmingham Clinical Research Unit has 2 clinical trials on record, with 1 currently active. Their work covers Type 2 Diabetes Mellitus (T2DM), Meningococcal Immunisation, Healthy Volunteers.
Accel Research Site - Birmingham Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.